|
|
|
|
| Symbol | Name | 1-Week
Relative Strength | 2-Week
Relative Strength | 4-Week
Relative Strength | 13-Week
Relative Strength | 26-Week
Relative Strength | 52-Week
Relative Strength | Last | Volume |
| |
FuelCell Energy Inc. | 88 /100 | 90 /100 | 99 /100 | 99 /100 | 99 /100 | 6 /100 | 2.40 |
23,854,445 |
| |
Synthorx Inc. | 19 /100 | 21 /100 | 33 /100 | 99 /100 | 99 /100 | 99 /100 | 68.03 |
304,787 |
| |
ChemoCentryx Inc. | 94 /100 | 93 /100 | 91 /100 | 99 /100 | 99 /100 | 98 /100 | 43.66 |
1,422,923 |
| |
Oncolytics Biotech Inc. | 0 /100 | 2 /100 | 98 /100 | 99 /100 | 97 /100 | 87 /100 | 3.10 |
1,190,444 |
| |
Arbutus Biopharma Corp | 49 /100 | 68 /100 | 94 /100 | 99 /100 | 93 /100 | 21 /100 | 3.07 |
217,309 |
| |
Aurinia Pharmaceuticals Inc. | 24 /100 | 18 /100 | 43 /100 | 99 /100 | 99 /100 | 97 /100 | 20.08 |
1,739,612 |
| |
ContraFect Corp. | 22 /100 | 99 /100 | 99 /100 | 99 /100 | 98 /100 | 94 /100 | 1.04 |
2,055,952 |
| |
Dermira Inc. | 31 /100 | 96 /100 | 96 /100 | 99 /100 | 98 /100 | 98 /100 | 19.155 |
3,241,890 |
| |
Trillium Therapeutics Inc. | 13 /100 | 99 /100 | 99 /100 | 99 /100 | 99 /100 | 87 /100 | 2.67 |
3,015,169 |
| |
Adaptimmune Therapeutics PLC ADR | 99 /100 | 99 /100 | 99 /100 | 99 /100 | 88 /100 | 28 /100 | 4.52 |
1,866,617 |
|
Please sign up for viewing the full list of stocks. |
|
|
|
| |
NYSE
TSX
LSE
XETRA
HKSE
NSE
SES
ASX
NZX
MOEX
TADAWUL
BM
ISE
